West Pharmaceutical Services (WST) News Today → 🚀 Tap into this explosive trade opportunity asap (From Daily Strike Alliance) (Ad) Free WST Stock Alerts $324.59 +1.74 (+0.54%) (As of 10:00 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 10:08 AM | marketbeat.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by Allianz Asset Management GmbHAllianz Asset Management GmbH boosted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 37.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 186,027May 29 at 2:31 PM | msn.comDowningtown Area School District Receives $150K Grant from West Pharmaceutical ServicesMay 29 at 11:37 AM | marketbeat.comTD Asset Management Inc Has $232.24 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)TD Asset Management Inc raised its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 38.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 659,560 shares of the medical instruMay 29 at 6:00 AM | prnewswire.comWest Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene TherapyMay 28 at 6:00 AM | prnewswire.comWest to Participate in Upcoming Investor ConferenceMay 28 at 5:59 AM | marketbeat.comUBS Group AG Grows Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)UBS Group AG raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 15.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 82,290 shares of the medical instruments supplier's stock afMay 27 at 12:49 PM | marketbeat.comArtisan Partners Limited Partnership Has $690.53 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)Artisan Partners Limited Partnership raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 23.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,961,063 shares of the mediMay 26, 2024 | marketbeat.comIntech Investment Management LLC Increases Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Intech Investment Management LLC lifted its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 150.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,020 shares of the medical instruments supplierMay 24, 2024 | insidermonkey.comHere’s Why West Pharmaceutical Services (WST) Bounced Back in Q1May 23, 2024 | marketbeat.comGW&K Investment Management LLC Sells 12,421 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)GW&K Investment Management LLC lessened its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 26.8% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 33,947 shares of the medical instruments supplier's stock after selling 12,421May 22, 2024 | marketbeat.com17,005 Shares in West Pharmaceutical Services, Inc. (NYSE:WST) Acquired by Trexquant Investment LPTrexquant Investment LP acquired a new stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 17,005 shares of the medical instruments supplier's sMay 21, 2024 | marketbeat.comDynamic Technology Lab Private Ltd Buys Shares of 3,017 West Pharmaceutical Services, Inc. (NYSE:WST)Dynamic Technology Lab Private Ltd acquired a new stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,017 shares of the medical instruments supplier's stocMay 20, 2024 | marketbeat.comFranklin Resources Inc. Has $741.42 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Franklin Resources Inc. increased its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,105,589 shares of the medical instruments supplier's stock after buying an addMay 20, 2024 | americanbankingnews.comQ2 2024 Earnings Forecast for West Pharmaceutical Services, Inc. Issued By Zacks Research (NYSE:WST)May 19, 2024 | marketbeat.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by Brown Advisory Inc.Brown Advisory Inc. lifted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,414,431 shares of the medical instruments supplier'sMay 18, 2024 | marketbeat.comMizuho Markets Americas LLC Has $4.31 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Mizuho Markets Americas LLC raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 41.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 12,229 shares of the medical instruments suppliMay 17, 2024 | marketbeat.comQ4 2024 EPS Estimates for West Pharmaceutical Services, Inc. (NYSE:WST) Increased by AnalystWest Pharmaceutical Services, Inc. (NYSE:WST - Free Report) - Research analysts at Zacks Research boosted their Q4 2024 EPS estimates for West Pharmaceutical Services in a report released on Thursday, May 16th. Zacks Research analyst I. Bandyopadhyay now expects that the medical instruments supplMay 16, 2024 | marketbeat.comWest Pharmaceutical Services Q1 Earnings TranscriptMay 14, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Has $233.50 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)Massachusetts Financial Services Co. MA increased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 15.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 663,135 shares of the mMay 11, 2024 | marketbeat.comVersor Investments LP Buys Shares of 4,070 West Pharmaceutical Services, Inc. (NYSE:WST)Versor Investments LP purchased a new stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,070 shares of the medical inMay 11, 2024 | seekingalpha.comWest Pharmaceutical: Pick And Shovels Of The Injectable Drug IndustryMay 11, 2024 | insidertrades.comEric Mark Green Sells 66,000 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) StockMay 9, 2024 | marketbeat.comInsider Selling: West Pharmaceutical Services, Inc. (NYSE:WST) CEO Sells 66,000 Shares of StockWest Pharmaceutical Services, Inc. (NYSE:WST - Get Free Report) CEO Eric Mark Green sold 66,000 shares of West Pharmaceutical Services stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total transaction of $24,198,900.00. Following the sale, the chief executive officer now owns 152,908 shares of the company's stock, valued at $56,063,718.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.May 8, 2024 | marketbeat.comNational Bank of Canada FI Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)National Bank of Canada FI decreased its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 20.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 41,857 shares of the medical instruments supplier's stock after selling 1May 7, 2024 | marketbeat.comNatixis Advisors L.P. Decreases Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Natixis Advisors L.P. lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 6.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 46,558 shares of the medical instruments supplier's stock after selling 3,May 6, 2024 | msn.comWest Pharmaceutical Services to Present at Bank of America Securities Healthcare ConferenceMay 5, 2024 | marketbeat.comSwiss National Bank Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST)Swiss National Bank lowered its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 231,000 shares of the medical instruMay 4, 2024 | marketbeat.comTCG Advisory Services LLC Buys Shares of 2,225 West Pharmaceutical Services, Inc. (NYSE:WST)TCG Advisory Services LLC purchased a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 2,225 shares of the medical instruments supplier's stock, valued at approximateMay 2, 2024 | marketbeat.comTruist Financial Corp Cuts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Truist Financial Corp lowered its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 12.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,338 shares of the medical instruments supplier's sApril 30, 2024 | finance.yahoo.comWest Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call TranscriptApril 30, 2024 | marketbeat.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 7.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 131,425 shares of the medical instruments supplier's stApril 30, 2024 | prnewswire.comWest to Participate in Upcoming Investor ConferenceApril 29, 2024 | msn.comWest Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year GuidanceApril 28, 2024 | marketbeat.comParadiem LLC Has $3.49 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Paradiem LLC cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 21.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,898 shares of the medical instruments supplier's stock after selApril 28, 2024 | finance.yahoo.comWest Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsApril 27, 2024 | seekingalpha.comWest Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call TranscriptApril 27, 2024 | marketbeat.comBank Julius Baer & Co. Ltd Zurich Purchases Shares of 8,207 West Pharmaceutical Services, Inc. (NYSE:WST)Bank Julius Baer & Co. Ltd Zurich purchased a new stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 8,207 shares of the medical instruments supplier's stock, valued at approximately $2,890,00April 26, 2024 | marketbeat.comStevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Stevens Capital Management LP purchased a new stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 5,546 shares of the medical instrumentsApril 26, 2024 | markets.businessinsider.comWest Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy RatingApril 26, 2024 | marketbeat.comWest Pharmaceutical Services (NYSE:WST) Releases Quarterly Earnings Results, Beats Expectations By $0.27 EPSWest Pharmaceutical Services (NYSE:WST - Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.27. The firm had revenue of $695.40 million for the quarter, compared to analyst estimates of $670.62 million. West Pharmaceutical Services had a net margin of 20.12% and a return on equity of 21.60%. The company's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.98 EPS.April 26, 2024 | finance.yahoo.comWest Pharmaceutical Services First Quarter 2024 Earnings: Beats ExpectationsApril 26, 2024 | marketbeat.comWest Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)West Pharmaceutical Services, Inc. (NYSE:WST) declared a quarterly dividend on Thursday, April 25th. Stockholders of record on Wednesday, July 31st will be paid a dividend of 0.20 per share by the medical instruments supplier on Wednesday, August 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.22%. The ex-dividend date is Wednesday, July 31st.April 26, 2024 | finance.yahoo.comWest Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...April 25, 2024 | seekingalpha.comWest Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call PresentationApril 25, 2024 | finanznachrichten.deWest Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendApril 25, 2024 | marketbeat.comWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Illinois Municipal Retirement FundIllinois Municipal Retirement Fund trimmed its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 63.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,April 25, 2024 | gurufocus.comWest Pharmaceutical Services Inc. (WST) Q1 2024 Earnings: Adjusted EPS Rises Amidst Sales DeclineApril 25, 2024 | marketbeat.comWest Pharmaceutical Services (NYSE:WST) Releases FY 2024 Earnings GuidanceWest Pharmaceutical Services (NYSE:WST) updated its FY 2024 earnings guidance. The company provided EPS guidance of 7.630-7.880 for the period, compared to the consensus estimate of 7.620. The company also issued revenue guidance of $3.0 billionillion-$3.0 billionillion, compared to the consensus estimate of $3.0 billionillion.April 25, 2024 | reuters.comWest Pharma posts beat-and-raise quarter aided by strong demand for injectablesApril 25, 2024 | prnewswire.comWest Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend Get West Pharmaceutical Services News Delivered to You Automatically Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Email Address RE: Your account status (Ad)Your $200 MarketBeat account credit expires in less than twelve hours. Upgrade to MarketBeat All Access today and save $200 on your 2024-2025 MarketBeat premium subscription. Claim My Discount WST Media Mentions By Week WST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WST News Sentiment▼0.830.80▲Average Medical News Sentiment WST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WST Articles This Week▼96▲WST Articles Average Week Get West Pharmaceutical Services News Delivered to You Automatically Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALGN News Today COO News Today XRAY News Today MMSI News Today HAE News Today NEOG News Today QDEL News Today ICUI News Today STAA News Today ATRI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:WST) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
